SlideShare a Scribd company logo
Monitoring ART cycle
Aboubakr Elnashar
Benha university Hospital, Egypt
Aboubakr Elnashar
CONTENTS
I. METHODS OF MONITORING
II. OBJECTIVES OF MONOTORING
1. Prediction of ovarian response prior to COS
2. Monitor the effect of pituitary down-regulation.
3. Evaluate whether the dose of Gnt is adequate
or not
4. Prevention of OHSS.
5. Find the optimal time to give hCG.
6. Avoid cycle cancellation
III. CONCLUSION 3Aboubakr Elnashar
I. METHODS OF MONITORING
1. US:
 measurements of follicular growth
 endometrial thickness.
2. US and serum E2.
3. Power Doppler imaging
Perifollicular blood flow
4. 3D US.
 TVS is the most practical way {actual response of
ovaries and uterus}
Aboubakr Elnashar
II. OBJECTIVES OF MONOTORING
1. Prediction of ovarian response prior to COS
2. Monitor the effect of pituitary down-regulation.
3. Evaluate whether the dose of Gnt is adequate or
not
4. Prevention of OHSS.
5. Find the optimal time to give hCG.
6. Prevention of cycle cancellationAboubakr Elnashar
1.Prediction of ovarian response to Gnt
Aim:1. Identify poor responder
2. Identify risk of OHSS
Important:
To choose optimal starting dose of FSH.
Methods: Basal AFC, FSH, AMH
 AFC: superior to basal day 3 FSH. as well as BMI for
predicting the number of oocytes retrieved for lVF.
(Ng et al, 2005)
 ≤6: longer duration
higher dose of Gnt
less oocytes retrieved.
increased risk of cycle cancellation before OR
 ≥16: High responder
Aboubakr Elnashar
2. Monitoring the effect of pituitary down-
regulation.
Before starting follicular stimulation:
confirm down regulation (Criteria of suppression):
Hormonal assay
1. E2 < 50 ng/ml
2. LH < 5.0 IU/ml,
3. P4 < 1 ng/m ng/ml
Aboubakr Elnashar
 TVS:
1. No ovarian cysts
2. Number of small follicles (<8 mm) ≤ 4
3. Endometrial thickness <6 mm predicts down
regulation in 95% of cases
4. Ovarian artery resistance index: 0.9 have the
highest specificity and PPV
If not: stimulation is postponed and the assays
repeated after 2—4 further days of down-regulation.
Aboubakr Elnashar
3. Evaluate whether the dose of GnT is
adequate or not.
1. TVS:
A. 1st US
 D4 Stimulation
In PCO
 D 5 or 6 stimulation
In normal responder
Number: 6-8 each ovary
 With diameter: 11- 12 mmAboubakr Elnashar
B. Follow up
 Daily or Every other day depending on follicle size
 How:
Each follicle is measured in two perpendicular planes.
Then, the average of the four largest diameters is calculated.
 mean of two, three or four diameters, measured in one or two planes.
 Measure the internal diameter of the follicle in two
planes and the average diameter is then calculated.
 Follicles usually grow by 2-3 mm/d.
Aboubakr Elnashar
2. Combining US and E2
In normal responders:
seldom changes the timing of hCG
does not increase PR or the risk of OHSS
(Lass et al, 2003)
E2 D6
300 -600 pg/ml
 D6 E2 < 60 pg/ml: PR 7.8 %
If ok: continue the same dose.
If less than that: increase by one ampoule.
If greater than that: decrease the dose by ½ -1
amp Aboubakr Elnashar
Important in
1. If risk for OHSS.
2. Poor responder
E2 D5 stimulation:
<700 pmol/l: FSH dose is increased by 75-150 u
US on stimulation D9 or 10.
This is a simple way of early discovery that the
starting dose has been sufficient.
3. US monitoring shows adequate follicular growth
but inadequate endometrial growth
{low E production/follicle due to a low endogenous
LH level}: add rec LH
Aboubakr Elnashar
3. Color Doppler
A significant increased oocyte recovery from follicles with a
high peak systolic velocity as measured by pulsed Doppler
and gray-scale ultrasound (Naigund et al, 2007)
Oocytes from poorly vascularized follicles produced
morphologically poor embryos as compared to oocytes from
highly vascularized follicles.
Follicles with normal perifollicular blood flow contained
oocytes free of cytoplasmatic or chromosomal/ spindle
defects. (Van Blerkom et al, 2008)
high-grade follicular vascularity resulted in oocytes/embryos
that had an increased potential for becoming a full-term
pregnancy. (Chui et al, 2009)
Quantitative and qualitative assessment of peri-
follicular flow allow for a more accurate assessment of
follicular competence. Follicles that have >75% of
their surface perfused, or where PSV is >10 cm/s,
appear to contain an oocyte of satisfactory quality.
Aboubakr Elnashar
4. Combination of power Doppler angiography
(PDA) and 3D-US
for predicting and monitoring ovarian response in IVF-ET
(embryo transfer) cycles.
technique really improves the monitoring of the cycle is still
unclear.
technique is complicated and time consuming, making it less
practical for the daily monitoring of ART cycles.
Aboubakr Elnashar
4. Prevention of OHSS.
 Predicting of hyper-response
1. Previous history of OHSS
2. The presence of PCOS
3. Younger age
4. Lower BMI
5. High AMH
Aboubakr Elnashar
1. US :
a. PCO pattern of response to GnRH before GnT
b. Number of follicles >20
 Number of small & intermediate size (10-14 mm)
>15
 No risk when immature follicles are < 15.
{Number of the immature follicles is more important
than the number of mature follicles in predicting
OHSS.
c. Doppler:
low intraovarian vascular resistance
Combination of E2 & US: best chance for prediction
Aboubakr Elnashar
2. E2: High or rapid slope
<1000 pg/ml: No OHSS
>3000-4000 pg/ml: HCG should be withheld
<3500 pg/mL: No OHSS (Asch et al 2005)
3500-5999 pg/mL: 1.5%
6000 pg/mL: 38%
Cases with severe OHSS are seen with E2 <1500
pg/ml.
Small fraction of cases will be with excessive E2:
slope of rise of E2 is more accurate (considered if
the value is doubled).
Aboubakr Elnashar
Do not trigger ovulation with the intention of fresh
ET in women who have:
E2>3500 pg/ml or
>20 follicles on US
(NICE, 2013)
Aboubakr Elnashar
5. Find the optimal time to give hCG.
Ovulation when?
35-42 h after the onset of LH surge which triggers
resumption of meiosis inside the oocyte
HCG when?
3 or more follicles of size ≥17 mm
Endometrial thickness more than 8 mm
Aboubakr Elnashar
OR when?
When most of the follicles are large enough to
suggest the presence of mature oocytes.
Optimal oocyte recovery and fertilization rates can
be obtained from follicles between 14 and 24 mm in
diameter.
Oocyte recovery rates start to decrease after the
follicles exceed 24 mm in diameter.
No difference in the oocyte quality obtained from
follicles between 18 and 22 mm in diameter: more
convenient and predictable planning of oocyte
collection.
At least 35 h after HCG
Aboubakr Elnashar
US signs of impaired implantation at the time of
hCG administration
1. An endometrial thickness of <7 mm
2. Endometrial volume <2 cm3
3. Endometrial thickness >14 mm
4. Absence of multilayered endometrium
5. Uterine artery PI >3.0
6. Absence of subendometrial or reduction in the
endometrial vascularized area
Aboubakr Elnashar
If Endometrial thickness ≤7
1. Prolong ovulation induction until endometrial
thickness of >7 mm is achieved.
2. If pregnancy is not achieved, in a subsequent
cycle the ovulation induction regimen is changed
to allow for a better endometrial development.
Aboubakr Elnashar
6. Cycle cancellation
Define:
discontinuation of ovarian stimulation prematurely
without oocyte retrival.
Incidence
12% of all IVF cycles are cancelled before egg
collection.
Women's age Cancellation rate
Less than 35 7.7-10%
35-37 11.6-14.7%
38-40 14.6-19.5%
Over 40 19.1-24.6%
Aboubakr Elnashar
The main reasons
1.No or poor egg production (83%)
2.Patient’s personal reasons (10%)
3.Excessive response to ovarian stimulation and
risk of developing OHSS (5%)
4.Medical illness (1%).
(SART 2005 and HFEA 2006 Reports).
AMH:
all cases that was cancelled due to poor response
had AMH < 0.4 ng/ml. (La Marca et al., 2006)
all cases that was cancelled due to high risk of
OHSS had AMH >7 ng/ml.
Aboubakr Elnashar
Indications
1. Follicular growth is delayed:
ovarian stimulation over 10 days:
< 3 follicles > 16 mm & E2 < 600 pg/ml.
2.OHSS is suspected:
each ovary contains > 10 follicles < 16 mm &
E2 > 3500 pg/ml
Ovary size > 80 mm
3. Basal LH is elevated:
LH > 10 IU/l or a premature LH surge occurs
4. Elevated serum P4:
>1.5 ng/ml is detected prior to ovulation induction.
Aboubakr Elnashar
CONCLUSION
Two-dimensional ultrasound scanning of follicular
size is still the method of choice for monitoring IVF
cycles, irrespective of the protocol used for COH.
It is the most practical, and is still reliable enough
for monitoring ovarian stimulation with
gonadotropins.
Combining ultrasound monitoring of follicular size
with E2 is particularly valuable for monitoring poor
responders as well as those at risk for OHSS.
Aboubakr Elnashar
Thank youAboubakr Elnashar

More Related Content

What's hot

AN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMENAN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMEN
Vasundhara Hospital & Fertility Research Centre Jaipur
 
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANIOVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
NICE Guidelines 2013, in relation to IUI & IVF Dr. Jyoti Agarwal,Dr. Sharda J...
NICE Guidelines 2013, in relation to IUI & IVF Dr. Jyoti Agarwal,Dr. Sharda J...NICE Guidelines 2013, in relation to IUI & IVF Dr. Jyoti Agarwal,Dr. Sharda J...
NICE Guidelines 2013, in relation to IUI & IVF Dr. Jyoti Agarwal,Dr. Sharda J...Lifecare Centre
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
Aboubakr Elnashar
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
POOR RESPONDERS
POOR RESPONDERS POOR RESPONDERS
POOR RESPONDERS
Meenakshi Vempalli
 
Repeated implantation failure.warda full
Repeated implantation failure.warda fullRepeated implantation failure.warda full
Repeated implantation failure.warda full
Osama Warda
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
sunitafeme
 
Controlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVFControlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVF
Aboubakr Elnashar
 
Ovulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUI
Bharati Dhorepatil
 
Role of LH in Controlled Ovarian Stimulation
Role of LH in Controlled Ovarian StimulationRole of LH in Controlled Ovarian Stimulation
Role of LH in Controlled Ovarian Stimulation
Sandro Esteves
 
Ivf in pcos
Ivf in pcosIvf in pcos
Ivf in pcos
Aboubakr Elnashar
 
Thin Endometrium & Infertility
Thin Endometrium & InfertilityThin Endometrium & Infertility
Thin Endometrium & Infertility
Lifecare Centre
 
Poor ovarian Response
Poor ovarian ResponsePoor ovarian Response
Poor ovarian ResponseManal Kamel
 
Top Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve ThemTop Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve ThemSandro Esteves
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation Protocols
Hesham Gaber
 
Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??
NARENDRA C MALHOTRA
 
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLES
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLESENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLES
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLES
Aboubakr Elnashar
 
Repeated Implantation failure
Repeated Implantation failureRepeated Implantation failure
Repeated Implantation failure
Ahmad Saber
 
Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF
Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVFLuteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF
Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF
Dr.Laxmi Agrawal Shrikhande
 

What's hot (20)

AN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMENAN IDEAL OVULATION INDUCTION REGIMEN
AN IDEAL OVULATION INDUCTION REGIMEN
 
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANIOVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
 
NICE Guidelines 2013, in relation to IUI & IVF Dr. Jyoti Agarwal,Dr. Sharda J...
NICE Guidelines 2013, in relation to IUI & IVF Dr. Jyoti Agarwal,Dr. Sharda J...NICE Guidelines 2013, in relation to IUI & IVF Dr. Jyoti Agarwal,Dr. Sharda J...
NICE Guidelines 2013, in relation to IUI & IVF Dr. Jyoti Agarwal,Dr. Sharda J...
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
POOR RESPONDERS
POOR RESPONDERS POOR RESPONDERS
POOR RESPONDERS
 
Repeated implantation failure.warda full
Repeated implantation failure.warda fullRepeated implantation failure.warda full
Repeated implantation failure.warda full
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
 
Controlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVFControlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVF
 
Ovulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUI
 
Role of LH in Controlled Ovarian Stimulation
Role of LH in Controlled Ovarian StimulationRole of LH in Controlled Ovarian Stimulation
Role of LH in Controlled Ovarian Stimulation
 
Ivf in pcos
Ivf in pcosIvf in pcos
Ivf in pcos
 
Thin Endometrium & Infertility
Thin Endometrium & InfertilityThin Endometrium & Infertility
Thin Endometrium & Infertility
 
Poor ovarian Response
Poor ovarian ResponsePoor ovarian Response
Poor ovarian Response
 
Top Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve ThemTop Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve Them
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation Protocols
 
Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??
 
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLES
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLESENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLES
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLES
 
Repeated Implantation failure
Repeated Implantation failureRepeated Implantation failure
Repeated Implantation failure
 
Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF
Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVFLuteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF
Luteal phase support in IUI and ART | Dr. Laxmi Shrikhande | ShrikhandeIVF
 

Similar to Monitoring ART cycle Aboubakr Elnashar

Is ultrasound monitoring alone enough in ART cycle?
Is ultrasound monitoring alone enough in ART cycle?Is ultrasound monitoring alone enough in ART cycle?
Is ultrasound monitoring alone enough in ART cycle?
Aboubakr Elnashar
 
OHSS: Prediction and prevention in non IVF cycles
OHSS:  Prediction and prevention in  non IVF cyclesOHSS:  Prediction and prevention in  non IVF cycles
OHSS: Prediction and prevention in non IVF cycles
Aboubakr Elnashar
 
OVARIAN RESERVE
OVARIAN RESERVEOVARIAN RESERVE
OVARIAN RESERVE
Aboubakr Elnashar
 
Follicular monitoring
Follicular monitoring Follicular monitoring
Follicular monitoring
Chandni Wadhwani
 
Patient preparation before IVF
Patient preparation before IVFPatient preparation before IVF
Patient preparation before IVF
Aboubakr Elnashar
 
Abnormal Uterine Bleeding1107 Holm
Abnormal Uterine Bleeding1107 HolmAbnormal Uterine Bleeding1107 Holm
Abnormal Uterine Bleeding1107 HolmMedicineAndHealth14
 
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
Aboubakr Elnashar
 
Emergency ultrasonography in 2nd 3rd timester
Emergency ultrasonography in 2nd 3rd timesterEmergency ultrasonography in 2nd 3rd timester
Emergency ultrasonography in 2nd 3rd timester
Aboubakr Elnashar
 
Infertility management 2019
Infertility management 2019Infertility management 2019
Infertility management 2019
Aboubakr Elnashar
 
Intrapartum fetal monitering
Intrapartum fetal moniteringIntrapartum fetal monitering
Intrapartum fetal moniteringdrmcbansal
 
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal Lifecare Centre
 
Abnormal uterine bleeding
Abnormal  uterine bleedingAbnormal  uterine bleeding
Abnormal uterine bleeding
Aboubakr Elnashar
 
Practical tips for monitoring of an iui cycle
Practical tips for monitoring of an iui cyclePractical tips for monitoring of an iui cycle
Practical tips for monitoring of an iui cycleLifecare Centre
 
Blood transfusion in ostetrics2019
Blood transfusion in ostetrics2019Blood transfusion in ostetrics2019
Blood transfusion in ostetrics2019
Aboubakr Elnashar
 
Gynaecological emergency
Gynaecological emergencyGynaecological emergency
Gynaecological emergencyobsgynhsnz
 
Intrauterine Insemination
Intrauterine  InseminationIntrauterine  Insemination
Intrauterine Insemination
Aboubakr Elnashar
 
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS           Prof. Aboubakr ElnasharART PREGNANCY COMPLICATIONS           Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
Aboubakr Elnashar
 
ART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONSART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONS
Aboubakr Elnashar
 
Management of adenxal mass during pregnancy
Management of adenxal mass during pregnancyManagement of adenxal mass during pregnancy
Management of adenxal mass during pregnancy
Aboubakr Elnashar
 
Principle of fetal monitoring
Principle of fetal monitoringPrinciple of fetal monitoring
Principle of fetal monitoringDr. Rubz
 

Similar to Monitoring ART cycle Aboubakr Elnashar (20)

Is ultrasound monitoring alone enough in ART cycle?
Is ultrasound monitoring alone enough in ART cycle?Is ultrasound monitoring alone enough in ART cycle?
Is ultrasound monitoring alone enough in ART cycle?
 
OHSS: Prediction and prevention in non IVF cycles
OHSS:  Prediction and prevention in  non IVF cyclesOHSS:  Prediction and prevention in  non IVF cycles
OHSS: Prediction and prevention in non IVF cycles
 
OVARIAN RESERVE
OVARIAN RESERVEOVARIAN RESERVE
OVARIAN RESERVE
 
Follicular monitoring
Follicular monitoring Follicular monitoring
Follicular monitoring
 
Patient preparation before IVF
Patient preparation before IVFPatient preparation before IVF
Patient preparation before IVF
 
Abnormal Uterine Bleeding1107 Holm
Abnormal Uterine Bleeding1107 HolmAbnormal Uterine Bleeding1107 Holm
Abnormal Uterine Bleeding1107 Holm
 
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
Emergency ultrasonography in 2nd 3rd timester
Emergency ultrasonography in 2nd 3rd timesterEmergency ultrasonography in 2nd 3rd timester
Emergency ultrasonography in 2nd 3rd timester
 
Infertility management 2019
Infertility management 2019Infertility management 2019
Infertility management 2019
 
Intrapartum fetal monitering
Intrapartum fetal moniteringIntrapartum fetal monitering
Intrapartum fetal monitering
 
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
 
Abnormal uterine bleeding
Abnormal  uterine bleedingAbnormal  uterine bleeding
Abnormal uterine bleeding
 
Practical tips for monitoring of an iui cycle
Practical tips for monitoring of an iui cyclePractical tips for monitoring of an iui cycle
Practical tips for monitoring of an iui cycle
 
Blood transfusion in ostetrics2019
Blood transfusion in ostetrics2019Blood transfusion in ostetrics2019
Blood transfusion in ostetrics2019
 
Gynaecological emergency
Gynaecological emergencyGynaecological emergency
Gynaecological emergency
 
Intrauterine Insemination
Intrauterine  InseminationIntrauterine  Insemination
Intrauterine Insemination
 
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS           Prof. Aboubakr ElnasharART PREGNANCY COMPLICATIONS           Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
 
ART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONSART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONS
 
Management of adenxal mass during pregnancy
Management of adenxal mass during pregnancyManagement of adenxal mass during pregnancy
Management of adenxal mass during pregnancy
 
Principle of fetal monitoring
Principle of fetal monitoringPrinciple of fetal monitoring
Principle of fetal monitoring
 

More from Aboubakr Elnashar

hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
Aboubakr Elnashar
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
Aboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
Aboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
Aboubakr Elnashar
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
Aboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
Aboubakr Elnashar
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
Aboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
Aboubakr Elnashar
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
Aboubakr Elnashar
 
Female infertility
Female infertility Female infertility
Female infertility
Aboubakr Elnashar
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
Aboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
Aboubakr Elnashar
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
Aboubakr Elnashar
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
Aboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
Aboubakr Elnashar
 
Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
Aboubakr Elnashar
 
update on PCOS
update on PCOSupdate on PCOS
update on PCOS
Aboubakr Elnashar
 

More from Aboubakr Elnashar (20)

hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 
Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
 
update on PCOS
update on PCOSupdate on PCOS
update on PCOS
 

Recently uploaded

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
SwisschemDerma
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 

Recently uploaded (20)

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 

Monitoring ART cycle Aboubakr Elnashar

  • 1. Monitoring ART cycle Aboubakr Elnashar Benha university Hospital, Egypt Aboubakr Elnashar
  • 2. CONTENTS I. METHODS OF MONITORING II. OBJECTIVES OF MONOTORING 1. Prediction of ovarian response prior to COS 2. Monitor the effect of pituitary down-regulation. 3. Evaluate whether the dose of Gnt is adequate or not 4. Prevention of OHSS. 5. Find the optimal time to give hCG. 6. Avoid cycle cancellation III. CONCLUSION 3Aboubakr Elnashar
  • 3. I. METHODS OF MONITORING 1. US:  measurements of follicular growth  endometrial thickness. 2. US and serum E2. 3. Power Doppler imaging Perifollicular blood flow 4. 3D US.  TVS is the most practical way {actual response of ovaries and uterus} Aboubakr Elnashar
  • 4. II. OBJECTIVES OF MONOTORING 1. Prediction of ovarian response prior to COS 2. Monitor the effect of pituitary down-regulation. 3. Evaluate whether the dose of Gnt is adequate or not 4. Prevention of OHSS. 5. Find the optimal time to give hCG. 6. Prevention of cycle cancellationAboubakr Elnashar
  • 5. 1.Prediction of ovarian response to Gnt Aim:1. Identify poor responder 2. Identify risk of OHSS Important: To choose optimal starting dose of FSH. Methods: Basal AFC, FSH, AMH  AFC: superior to basal day 3 FSH. as well as BMI for predicting the number of oocytes retrieved for lVF. (Ng et al, 2005)  ≤6: longer duration higher dose of Gnt less oocytes retrieved. increased risk of cycle cancellation before OR  ≥16: High responder Aboubakr Elnashar
  • 6. 2. Monitoring the effect of pituitary down- regulation. Before starting follicular stimulation: confirm down regulation (Criteria of suppression): Hormonal assay 1. E2 < 50 ng/ml 2. LH < 5.0 IU/ml, 3. P4 < 1 ng/m ng/ml Aboubakr Elnashar
  • 7.  TVS: 1. No ovarian cysts 2. Number of small follicles (<8 mm) ≤ 4 3. Endometrial thickness <6 mm predicts down regulation in 95% of cases 4. Ovarian artery resistance index: 0.9 have the highest specificity and PPV If not: stimulation is postponed and the assays repeated after 2—4 further days of down-regulation. Aboubakr Elnashar
  • 8. 3. Evaluate whether the dose of GnT is adequate or not. 1. TVS: A. 1st US  D4 Stimulation In PCO  D 5 or 6 stimulation In normal responder Number: 6-8 each ovary  With diameter: 11- 12 mmAboubakr Elnashar
  • 9. B. Follow up  Daily or Every other day depending on follicle size  How: Each follicle is measured in two perpendicular planes. Then, the average of the four largest diameters is calculated.  mean of two, three or four diameters, measured in one or two planes.  Measure the internal diameter of the follicle in two planes and the average diameter is then calculated.  Follicles usually grow by 2-3 mm/d. Aboubakr Elnashar
  • 10. 2. Combining US and E2 In normal responders: seldom changes the timing of hCG does not increase PR or the risk of OHSS (Lass et al, 2003) E2 D6 300 -600 pg/ml  D6 E2 < 60 pg/ml: PR 7.8 % If ok: continue the same dose. If less than that: increase by one ampoule. If greater than that: decrease the dose by ½ -1 amp Aboubakr Elnashar
  • 11. Important in 1. If risk for OHSS. 2. Poor responder E2 D5 stimulation: <700 pmol/l: FSH dose is increased by 75-150 u US on stimulation D9 or 10. This is a simple way of early discovery that the starting dose has been sufficient. 3. US monitoring shows adequate follicular growth but inadequate endometrial growth {low E production/follicle due to a low endogenous LH level}: add rec LH Aboubakr Elnashar
  • 12. 3. Color Doppler A significant increased oocyte recovery from follicles with a high peak systolic velocity as measured by pulsed Doppler and gray-scale ultrasound (Naigund et al, 2007) Oocytes from poorly vascularized follicles produced morphologically poor embryos as compared to oocytes from highly vascularized follicles. Follicles with normal perifollicular blood flow contained oocytes free of cytoplasmatic or chromosomal/ spindle defects. (Van Blerkom et al, 2008) high-grade follicular vascularity resulted in oocytes/embryos that had an increased potential for becoming a full-term pregnancy. (Chui et al, 2009) Quantitative and qualitative assessment of peri- follicular flow allow for a more accurate assessment of follicular competence. Follicles that have >75% of their surface perfused, or where PSV is >10 cm/s, appear to contain an oocyte of satisfactory quality. Aboubakr Elnashar
  • 13. 4. Combination of power Doppler angiography (PDA) and 3D-US for predicting and monitoring ovarian response in IVF-ET (embryo transfer) cycles. technique really improves the monitoring of the cycle is still unclear. technique is complicated and time consuming, making it less practical for the daily monitoring of ART cycles. Aboubakr Elnashar
  • 14. 4. Prevention of OHSS.  Predicting of hyper-response 1. Previous history of OHSS 2. The presence of PCOS 3. Younger age 4. Lower BMI 5. High AMH Aboubakr Elnashar
  • 15. 1. US : a. PCO pattern of response to GnRH before GnT b. Number of follicles >20  Number of small & intermediate size (10-14 mm) >15  No risk when immature follicles are < 15. {Number of the immature follicles is more important than the number of mature follicles in predicting OHSS. c. Doppler: low intraovarian vascular resistance Combination of E2 & US: best chance for prediction Aboubakr Elnashar
  • 16. 2. E2: High or rapid slope <1000 pg/ml: No OHSS >3000-4000 pg/ml: HCG should be withheld <3500 pg/mL: No OHSS (Asch et al 2005) 3500-5999 pg/mL: 1.5% 6000 pg/mL: 38% Cases with severe OHSS are seen with E2 <1500 pg/ml. Small fraction of cases will be with excessive E2: slope of rise of E2 is more accurate (considered if the value is doubled). Aboubakr Elnashar
  • 17. Do not trigger ovulation with the intention of fresh ET in women who have: E2>3500 pg/ml or >20 follicles on US (NICE, 2013) Aboubakr Elnashar
  • 18. 5. Find the optimal time to give hCG. Ovulation when? 35-42 h after the onset of LH surge which triggers resumption of meiosis inside the oocyte HCG when? 3 or more follicles of size ≥17 mm Endometrial thickness more than 8 mm Aboubakr Elnashar
  • 19. OR when? When most of the follicles are large enough to suggest the presence of mature oocytes. Optimal oocyte recovery and fertilization rates can be obtained from follicles between 14 and 24 mm in diameter. Oocyte recovery rates start to decrease after the follicles exceed 24 mm in diameter. No difference in the oocyte quality obtained from follicles between 18 and 22 mm in diameter: more convenient and predictable planning of oocyte collection. At least 35 h after HCG Aboubakr Elnashar
  • 20. US signs of impaired implantation at the time of hCG administration 1. An endometrial thickness of <7 mm 2. Endometrial volume <2 cm3 3. Endometrial thickness >14 mm 4. Absence of multilayered endometrium 5. Uterine artery PI >3.0 6. Absence of subendometrial or reduction in the endometrial vascularized area Aboubakr Elnashar
  • 21. If Endometrial thickness ≤7 1. Prolong ovulation induction until endometrial thickness of >7 mm is achieved. 2. If pregnancy is not achieved, in a subsequent cycle the ovulation induction regimen is changed to allow for a better endometrial development. Aboubakr Elnashar
  • 22. 6. Cycle cancellation Define: discontinuation of ovarian stimulation prematurely without oocyte retrival. Incidence 12% of all IVF cycles are cancelled before egg collection. Women's age Cancellation rate Less than 35 7.7-10% 35-37 11.6-14.7% 38-40 14.6-19.5% Over 40 19.1-24.6% Aboubakr Elnashar
  • 23. The main reasons 1.No or poor egg production (83%) 2.Patient’s personal reasons (10%) 3.Excessive response to ovarian stimulation and risk of developing OHSS (5%) 4.Medical illness (1%). (SART 2005 and HFEA 2006 Reports). AMH: all cases that was cancelled due to poor response had AMH < 0.4 ng/ml. (La Marca et al., 2006) all cases that was cancelled due to high risk of OHSS had AMH >7 ng/ml. Aboubakr Elnashar
  • 24. Indications 1. Follicular growth is delayed: ovarian stimulation over 10 days: < 3 follicles > 16 mm & E2 < 600 pg/ml. 2.OHSS is suspected: each ovary contains > 10 follicles < 16 mm & E2 > 3500 pg/ml Ovary size > 80 mm 3. Basal LH is elevated: LH > 10 IU/l or a premature LH surge occurs 4. Elevated serum P4: >1.5 ng/ml is detected prior to ovulation induction. Aboubakr Elnashar
  • 25. CONCLUSION Two-dimensional ultrasound scanning of follicular size is still the method of choice for monitoring IVF cycles, irrespective of the protocol used for COH. It is the most practical, and is still reliable enough for monitoring ovarian stimulation with gonadotropins. Combining ultrasound monitoring of follicular size with E2 is particularly valuable for monitoring poor responders as well as those at risk for OHSS. Aboubakr Elnashar